Zuellig Pharma Korea under siege

Published: 2009-06-15 06:58:00

Updated: 2009-06-15 06:58:00

Zuellig Pharma Korea is facing a bleak business outlook as domestic wholesalers, including ZPK associate wholesalers, are poised to go all-out in an attempt to fight against ZPK’s low margin and collateral policies.

ZPK has been enjoying dominance over its Korean rivals, but the company might ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK